medigraphic.com

2012, Number 1

<< Back Next >>

Enf Infec Microbiol 2012; 32 (1)

The evaluation of molecular diagnostic techniques for detection of infection with human papilloma virus in the mouth

Lucrecia MM, Medina MG, Merino LA

Language: Spanish
References: 32
Page: 25-30
PDF size: 148.77 Kb.


ABSTRACT

The human papillomavirus (HPV) is now considered the sexually transmitted infection (STI) most common in the world. Often, these infections are asymptomatic, passing unnoticed unless molecular methods are used. Other infections become chronic, with the greatest potential oncogenic. The virus was detected in oral squamous cell carcinoma and benign lesions of oral mucosa, where it was found high and low HPV oncogenic risk. In normal oral mucosa identified different types of high oncogenic risk HPV. Studies indicate that the finding of HPV in healthy mucosa depends on the method of study employed. However, despite the importance of early diagnosis, there is little information on the prevalence of HPV in oral mucosa healthy. HPV infection can be diagnosed by different methods, but not all the genome to detect or determine the viral type involved. HPV typing can find viral types circulating in a population, facilitating the development and implementation of programs for prevention, diagnosis and treatment, so the identification of high cancer risk HPV should be performed routinely. Although the best diagnostic methods are molecular testing should be considered the geographical prevalence of different types of HPV in the choice of specific method akin to avoid inaccurate conclusions. Finally, new methods of detection of oral HPV are being studied, considering benefits for prevention and treatment of oral cancer.


REFERENCES

  1. Rivera R, Delgado J, Prainel V, Barrero R, Larraín A. “Mecanismos de infección y transformación neoplásica producido por virus papiloma humano en el epitelio cervical”. Rev Chil Obstet Ginecol 2006; 71: 135-140.

  2. Moscicki AB, Schiffman M, Kjaer S, Villa LL, “Chapter 5: Updating the natural history of HPV and anogenital cancer”. Vaccine 2006; 24 (3): 42-51.

  3. De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. “Classification of papillomaviruses”. Virology 2004; 324: 17-27.

  4. Khan M, Castle P, Lorincz A, Wacholder S, Sherman M, Scott D, et al. “The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type –specific HPV testing in clinical practice”. J Nat Cancer Inst 2005; 97: 1072-1079.

  5. Jacobs MV, Zielinski D, Meijer CJ, Pol RP, VoorHorst FJ, De Schipper FA et al. « A simplified and reliable HPV testing of archival Papanicolaou cervical smears: application to cervical smears from cancer starting with cytologically normal smears”. Br J Cancer 2000; 82: 1421-6.

  6. Iftner T, Villa LL. “Chapter 12: Human Papillomavirus Technologies”. Journal of the Cancer Institute Monographs 2003: 31: 80-88.

  7. Correnti M, Rivera H, Cavazza ME. “Detection of human papillomaviruses of high oncogenic potential in oral squamous cell carcinoma in a Venezuelan population”. Oral Diseases 2004; 10: 163-166.

  8. Jiménez C, Correnti M, Salma N, Cavazza M, Perrone M. “Detección del Virus Papiloma Humano en entidades clínicas benignas de la cavidad bucal mediante la reacción en cadena de la polimersasa e hibridación molecular”. Acta Odontol Venez 2001; 39 (2): 1-6.

  9. Gutiérrez RA, Colacino MC, Picconi MA, Alonio V, Teysiée A, Keszler A. “Detección y tipificación de HPV en lesiones orales”. Dermatología Argentina 2006; XII (2): 114-118.

  10. Gradilone A, Vercillo R, Napolitano M, Cardinal G, Gazzaniga P, Silvetre J, Gandinni O, Tomao S, Agliano AM. “Prevalence of human papillomavirus, cytomegalovirus and Epstein-Barr virus in the cérvix healthy women”. J Med Virology 1996; 50: 1-4.

  11. Kellokoski JK, Syrajenen SM, Chan F, Yliskoski M, Syrjanen KJ. “Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections”. J Oral Pathol Med 1992; 21: 459-64.

  12. Shroyer KR, Greer RO. “Detection of human papillomavirus DNA by in situ DNA hybridization and polymerase chain reaction in premalignant and malignant oral lesions”. Oral Surg Oral Med Oral Pathol 1991; 71(6), 708-713.

  13. Meijer C, Snijders P, Castle P. “Cinical utility of HPV genotyping”. Gyn Oncol 2006; 103: 12-17.

  14. Z. De Guglielmo, A. Rodríguez. “Métodos utilizados en la identificación del virus de papiloma humano”. An. Sist. Sanit. Navar. 2010; 33 (1): 71-77

  15. Melo AA, Roa EI, Montenegro HS, Capurro VI, Roa SJC. “Estudio comparativo de detección del virus papiloma humano (VPH) en muestras citológicas y biopsias de cuello uterino”. Rev Med Chile 2005; 133: 639-644.

  16. García F, Barker B, Santos C, Brown EM, Nuno T, Giuliano A, et al. “Cross-sectional sudy of patient and physician collected cytology and human papillomavirus”. Obstet Gynecol 2003; 102: 266-72.

  17. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG et al. “Prevalence of human papillomavirus DNA in different histological of cervical adenomacarcinoma”. Am J Pathol 2000; 157: 1055-62.

  18. Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. “Detection of human polyomaviruses and papillomaviruses in reveals the prostate as a hábitat for multiple viral infections”. Prostate 2002; 53: 263-76.

  19. Lorenzato FR, Singer A, Ho L, Santos LC, Batista R de L, Lubambo TM et al. “Human papillomavirus detection for cervical cáncer prevention polymerase chain reaction in self-collected samples”. Am J Obstet Gynecol 2002; 186: 962-8.

  20. Shibata D, Martin WJ, Arnheim N. “Analysis of DNA sequences in forty years old paraffin-embedded sections: a bridge between molecular biology and classical”. Cancer Res 1988; 48: 4564-6.

  21. Peng HQ, Roth P, Caussy D, Rawls W. “Comparison of the cytobrush and cotton swabs in sampling for filter in siitu hybridization detection of human 16 and 18 DNA”. Acta Cytol 1988; 32: 311-3.

  22. Redondo Horcajo AM, Guerra Merino A, Pinedo Garrido, García Aranda R. “Prevention of cérvix cáncer. Comparison of the simple quality obtained using cotton swab or cervical brush”. Aten Primaria 2000; 38-41.

  23. Wright DK MM. “Sample preparation from paraffinembedded tissue”. In: Innis M GD, Sninsky J, White T, editor. PCR protocols. A guide to methods and applications. San Diego, CA: Editorial Academic Press, Inc; 1990:p 153-8.

  24. De Guglielmo CZ, Ávila HM, Correnti M, Veitía MD, Cavazza M. “Evaluación mediante RCP de la infección por el virus de papiloma humano en muestras de pacientes con diagnóstico clínico o citológico”. Rev Obstet Ginecol Venez 2008; 68(4): 240-247.

  25. González Losa MR, Manzano-Cabrera L,, Rueda Gordillo F, Hernández Solis SE, Puerto Solis M. “Low prevalence of high risk human papillomavirus in normal oral mucosa by hibrid capture 2”. Brazilian Journal of Microbioloy 2008; 39: 32-34.

  26. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, et al. “PCR detection of human papillomavirus comparison between MY09/11 and GP5+/6+ primers systems”. J Clin Microbiol 1997; 35: 1304-10.

  27. Cox T, Cuzick J. “HPV DNA testing in cervical cáncer screening: From evidence to policies”. Gynecol Oncol 2006; 103: 8-11.

  28. Castle P, Schiffmann M, Gravitt P, Fishman S, et al. “Comparisons of HPV DNA detection by MY09/11 PCR methods”. J Med Virol 2002; 68: 417-423.

  29. Aedo S, Melo A, García P, Guzmán P, Capurro I, Roa JC. “Detección y tipificación de Virus Papiloma Humano en lesiones preneoplásicas del cuello uterino mediante PCR-RFLP”. Rev Med Chile 2007; 135: 167-173.

  30. Graterol I, Finol H, Correnti M. “Virus del papiloma humano en lesiones intraepiteliales escamosas (LIE) de cuello uterino. Tipificación y ultraestructura”. Rev Soc Ven Microbiol 2006; 26: 89-94.

  31. Kay P, Meehan K, Williamson AL. “The use of nested polymerase chain reaction and restriction fragment lenght polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA”. Journal of virological methods 2002; 105: 159-170.

  32. Kornegay JR, Shepard AP, Hankins C, Lapointe N, Richardson H, Coutlée F, et al. “Non-isotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme.linked immunosorbent assay format”. J Clin Microbiol 2001; 39: 3530-6.




2020     |     www.medigraphic.com